The classification of a lancing device and lancets from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated May 14, 2025, you requested a tariff classification ruling on behalf of Ascensia Diabetes Care Holdings AG. During a phone call on June 10, 2025, you clarified that your request included the Microlet Next 2 Lancing Device and Microlet Next Lancets. Microlet Next Lancets are disposable blood lancets used with the Microlet family of lancing devices. Each blood lancet is composed of a stainless steel 28-gauge needle coated with silicone oil on the tip, a plastic cap, and a plastic holder.
One hundred pieces of the lancets are packaged in a box for retail sale. The Microlet Next 2 Lancing Device is a non-sterile, multiple use pen-like device for a single patient featuring a lancet ejector and a flexible vibration damping component. The lancing device has a removable black endcap having nine puncture depth settings for fingertip testing. It also has a clear non-adjustable endcap with a fixed puncture depth for palm alternative site testing.
A lancet will be inserted in the lancing device and when activated, the lancing device propels the lancet into the skin to obtain a blood sample for testing.
The applicable subheading for the Microlet Next Lancets will be 9018.39.0050, HTSUS, which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electro-medical apparatus and sight-testing instruments; parts and accessories thereof: [s]yringes, needles, catheters, cannulae and the like; parts and accessories thereof: [o]ther: [o]ther.” The general rate of duty will be free.
The applicable subheading for the Microlet Next 2 Lancing Device will be 9018.90.8000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences … parts and accessories thereof: [o]ther instruments and appliances and parts and accessories thereof: [o]ther: [o]ther.” The general rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e. 9903.01.24, in addition to subheading 9018.39.0050 or 9018.90.8000 . HTSUS, listed above.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time products from all countries will be subject to an additional 10 percent ad valorem rate of duty.
At the time of entry, you must report the Chapter 99 heading applicable to your product classification, i.e. 9903.01.25, in addition to subheading 9018.39.0050 or 9018.90.8000 , HTSUS, listed above.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N348999).